Delcath Systems (DCTH)
(Delayed Data from NSDQ)
$7.36 USD
-0.05 (-0.67%)
Updated Aug 14, 2024 04:00 PM ET
After-Market: $7.35 -0.01 (-0.14%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth A Momentum C VGM
Brokerage Reports
Delcath Systems, Inc. [DCTH]
Reports for Purchase
Showing records 101 - 120 ( 150 total )
Company: Delcath Systems, Inc.
Industry: Medical - Instruments
The Week Ahead in Life Sciences - Upcoming Events for the Week of October 14
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Delcath Systems, Inc.
Industry: Medical - Instruments
LIFE SCIENCES - The Week Ahead in Life Sciences - Upcoming Events for the Week of October 7
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Delcath Systems, Inc.
Industry: Medical - Instruments
Company: Delcath Systems, Inc.
Industry: Medical - Instruments
The Week Ahead in Life Sciences - Upcoming Events for the Week of September 30.
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Delcath Systems, Inc.
Industry: Medical - Instruments
The Week Ahead in Life Sciences - Upcoming Events for the Week of September 23
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Delcath Systems, Inc.
Industry: Medical - Instruments
September 2012 Potential Catalysts & Milestones - Monthly Update
Provider: WEDBUSH SECURITIES INC.
Company: Delcath Systems, Inc.
Industry: Medical - Instruments
The Week Ahead in Life Sciences - Upcoming Events for the Week of September 2, 2012
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Delcath Systems, Inc.
Industry: Medical - Instruments
Company: Delcath Systems, Inc.
Industry: Medical - Instruments
NDA Submission a Matter of Days, w/ Gen 2; Europe Building; Buy
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: Delcath Systems, Inc.
Industry: Medical - Instruments
Q2:12 EPS, Chemosat First Sales in Europe, US NDA Re- Submission on Track for Mid-August, Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: WADE G
Company: Delcath Systems, Inc.
Industry: Medical - Instruments
The Week Ahead in Life Sciences - Upcoming Events for the Week of July 29
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Delcath Systems, Inc.
Industry: Medical - Instruments
Healthcare - 2Q 2012: Quarterly Medical Technology Trading & Acquisition Valuation Update
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: Delcath Systems, Inc.
Industry: Medical - Instruments
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Delcath Systems, Inc.
Industry: Medical - Instruments
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Delcath Systems, Inc.
Industry: Medical - Instruments
ASCO Update - Positive Physician Commentary; Adjusting Model for Funding
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: Delcath Systems, Inc.
Industry: Medical - Instruments
ASCO Analyst Day Takeaways - CHEMOSAT Regional Therapy to Extend Life by Years; NDA Submission on Track for Aug 2012 - REITERATE OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: WADE G
Company: Delcath Systems, Inc.
Industry: Medical - Instruments
June 2012 Potential Catalysts & Milestones - Monthly Update
Provider: WEDBUSH SECURITIES INC.
Company: Delcath Systems, Inc.
Industry: Medical - Instruments
Med Tech Earnings Wrap-Up: What Looks Good Out of 1Q12
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: Delcath Systems, Inc.
Industry: Medical - Instruments
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Delcath Systems, Inc.
Industry: Medical - Instruments
NDA Submission Now Mid-August; Euro Experience Positive
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M